WEIGHT loss jabs could slow down Alzheimer’s disease and protect against dementia, a study suggests.
Imperial College London researchers found one of the injections reduced brain shrinkage and slowed memory loss.
In a trial on 204 UK patients with early-stage Alzheimer’s, half were given liraglutide, also known as Saxenda, and half received a placebo.
After a year, the weight jab patients had an 18 per cent slower decline in their brain function compared to the untreated patients.
MRI scans showed they also lost 50 per cent less brain tissue.
If the effects are proven in bigger trials it could be yet another breakthrough for the blockbuster drugs.
The GLP-1 receptor agonists, including Ozempic, Wegovy and Mounjaro, have already been found to burn off fat, battle type 2 diabetesand reduce the risk of strokes and …